BIOX · Bioceres Crop Solutions Corp. · Metrics
Market Cap
$26.17M
Shares
63.82M
BIOX metrics
64 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.42
Market cap
$26.17M
Price action
20 metricsPrice change (1W)
-4.6%
Price change (30D)
+18.8%
Price change (3M)
-0.4%
Price change (6M)
-17.8%
Price change (YTD)
-67.5%
Price change (1Y)
-81.0%
Trailing year
Price change (5Y)
-96.7%
52-week high
$2.24
52-week low
$0.32
Change from 52-week high
-81.0%
Change from 52-week low
+32.0%
Annualized volatility
102.4%
Annualized volatility (3M)
65.8%
Beta
1.7
RSI (14D)
54.1
Price vs SMA 50
+12.7%
Price vs SMA 200
-37.2%
Avg volume (3M)
272,059
Relative volume
0.3
Average dollar volume
$108,901
Company
3 metricsSector
Basic Materials
Industry
Agricultural Inputs
Shares outstanding
63.82M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,125.0%
P / book
0.3
reciprocal yield 292.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
0.3
reciprocal yield 312.8%
Earnings yield
-915.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-05-12
Profitability
9 metricsGross margin
39.3%
Operating margin
-1.4%
Trailing 12 months
Net margin
-16.5%
Gross profit (TTM)
$115.60M
Operating profit (TTM)
−$4.24M
Net income (TTM)
−$56.37M
Trailing 12 months
Diluted EPS (TTM)
$-3.78
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-25.3%
Year over year
Net income growth YoY
-1,396.1%
Revenue (TTM)
$294.42M
Trailing 12 months
EPS growth YoY
-125,473.9%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+0.0%
Revenue CAGR (5Y)
+14.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+42.0%
Quality
14 metricsReturn on equity
-21.8%
Return on assets
-7.7%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
-0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.06M
Total assets
$560.36M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$81.87M
Capital expenditures (TTM)
$3.51M
R&D (TTM)
$16.60M
SG&A (TTM)
—
Stock compensation (TTM)
$3.58M
R&D / revenue
5.6%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
29
13F filer change QoQ
-4
Institutional ownership
13.5%
Short interest
3 metricsShort interest
0.5%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
37 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1769484
CUSIP
G1117K114
13F (30d)
19 filings
19 filers
Visit website
Investor relations